Amsar da ta wuce kima game da cutar ta Covid ya bayyana abu ɗaya a sarari: da gaske ya kamata masu amfani da lafiya su yi nasu binciken kan lamuran kiwon lafiya da ke shafar su. Bugu da ƙari, bai isa kawai don neman "ra'ayi na biyu" ko ma "ra'ayi na uku" daga likitoci ba. Suna iya da kyau duka ba su da labari ko son zuciya. Har ila yau, wannan matsala ta riga ta riga ta riga ta faru na Covid.
Misali mai ban mamaki na wannan ana iya samuwa a cikin tarihin kwanan nan na gwajin cutar kansar prostate da magani, wanda, saboda dalilai na sirri, ya zama abin sha'awa a gare ni. A hanyoyi da yawa, yana kama da bala'in Covid, inda rashin amfani da gwajin PCR ya haifar da cutar da wanda ake zaton ya kamu da cutar ta Covid. magunguna masu lalata.
Littattafai biyu masu kyau a kan batun suna haskaka al'amuran da ke tattare da ciwon daji na prostate. Daya shine Mamaya na Prostate Snatchers Dr. Mark Scholz da Ralph Blum. Dr. Scholtz shine babban darektan hukumar Cibiyar Nazarin Ciwon Kankara ta Prostate in California. Sauran shine Babban Prostate Hoax Richard Ablin da Ronald Piana. Richard Ablin masanin ilimin cututtuka ne wanda ya ƙirƙira gwajin PSA amma ya zama babban mai sukar yadda ake amfani da shi a matsayin kayan aikin gano cutar kansar prostate.
Gwajin PSA na wajibi na shekara-shekara a cibiyoyi da yawa ya buɗe ma'adinin gwal ga masu ilimin urologist, waɗanda suka sami damar yin biopsies mai fa'ida da prostatectomies akan marasa lafiya waɗanda ke da lambobin gwajin PSA sama da wani matakin. Duk da haka, Ablin ya dage cewa "kallon PSA na yau da kullun yana cutar da maza fiye da kyau." Bugu da ƙari, ya ci gaba da cewa ma'aikatan kiwon lafiya da ke da hannu wajen yin gwajin cutar ta prostate da jiyya suna wakiltar "masana'antar ci gaba da kai da ta lalata miliyoyin maza na Amurka."
Ko da a lokacin sauraron amincewa don gwajin PSA, FDA ta san matsalolin da haɗari. Abu ɗaya, gwajin yana da ƙimar inganci na 78% na ƙarya. Matsayin PSA mai girma yana iya haifar da abubuwa daban-daban banda ciwon daji, don haka ba ainihin gwajin cutar kansar prostate bane. Bugu da ƙari, ƙididdige gwajin PSA na iya sa maza masu tsoratarwa su sami biopsies marasa mahimmanci da hanyoyin tiyata masu cutarwa.
Mutum daya da ya fahimci hadarin da ke tattare da gwajin da kyau shi ne shugaban kwamitin FDA, Dokta Harold Markovitz, wanda ya yanke shawarar ko zai amince da shi. Ya bayyana cewa, "Ina jin tsoron wannan gwajin, idan an amince da shi, zai fito tare da imprimatur na kwamitin ... kamar yadda aka nuna, ba za ku iya wanke hannayenku da laifi ba ... duk wannan yana barazana ga yawancin maza da ciwon prostate ... yana da haɗari."
A ƙarshe, kwamitin bai ba da izini mara izini ga gwajin PSA ba amma kawai ya amince da shi "tare da sharuɗɗa." Koyaya, daga baya, an yi watsi da yanayin.
Duk da haka, gwajin PSA ya zama biki a matsayin hanyar ceto daga ciwon gurguwar prostate. Sabis ɗin Wasiƙa har ma ya ba da tambari na haɓaka gwajin PSA na shekara a 1999. Mutane kaɗan ne suka zama masu arziki kuma sun shahara a kamfanin Hybritech, godiya ga gwajin Tandem-R PSA, samfurinsu mafi riba.
A wancan zamanin, lalacewar tasirin kamfanonin harhada magunguna kan na'urar likitanci da tsarin amincewa da magunguna ya riga ya bayyana. A cikin edita don Journal of Amirka Medical Association (wanda aka nakalto a cikin littafin Albin da Piana), Dokta Marcia Angell ta rubuta, “Kamfanonin harhada magunguna sun sami iko da ba a taɓa yin irinsa ba a kan kimanta samfuransu… akwai ƙarin shaidun da ke nuna cewa sun karkatar da binciken da suke ɗauka don sa magungunan su su yi kyau da aminci.” Ta kuma rubuta littafin littafin Gaskiya Game da Kamfanonin Magunguna: Yadda Suke Yaudare Mu da Abin da Za Mu Yi Game da shi.
Binciken ciwon daji yakan haifar da damuwa mai girma, amma a gaskiya, ciwon daji na prostate yana tasowa a hankali idan aka kwatanta da sauran cututtuka kuma ba sau da yawa yana haifar da barazana ga rayuwa. Taswirar da aka bayyana a littafin Scholz da Blum ya kwatanta matsakaicin tsawon rayuwar mutanen da ciwon daji ke dawowa bayan tiyata. Game da ciwon daji na hanji, suna rayuwa a matsakaicin shekaru biyu, amma masu ciwon gurguwar prostate suna rayuwa fiye da shekaru 18.5.
A mafi yawan lokuta, masu ciwon daji na prostate ba sa mutuwa daga gare ta sai dai daga wani abu dabam, ko an yi musu magani ko a'a. A cikin labarin 2023 game da wannan batu mai taken "Don Magani ko A'a," marubucin ya ba da rahoton sakamakon 15-shekara karatu na masu ciwon daji na prostate a cikin Jaridar Medicin ta New Englande. Kashi 3 cikin XNUMX na mazan da aka yi nazarin sun mutu ne da cutar sankara ta prostate, kuma samun radiation ko tiyata don hakan bai yi kama da bayar da fa'ida mai yawa na kididdiga ba akan "salon sa ido."
Dokta Scholz ya tabbatar da haka, yana rubuta cewa "nazarin ya nuna cewa waɗannan jiyya [radiation da tiyata] suna rage yawan mace-mace a cikin maza masu fama da ƙananan cututtuka da ƙananan haɗari da kawai 1% zuwa 2% kuma ta kasa da 10% a cikin maza masu fama da cutar hawan jini."
A zamanin yau tiyatar prostate shine zaɓin magani mai haɗari, amma har yanzu likitoci sun ba da shawarar sosai, musamman a Japan. Abin baƙin ciki, shi ma yana da alama ba dole ba ne. Ɗaya daga cikin binciken da aka ambata a littafin Ablin da Piana ya kammala cewa "Yin gwajin yawan jama'a na PSA ya haifar da karuwa mai yawa a cikin adadin prostatectomies mai raɗaɗi.
Duk da haka, da yawa daga cikin likitocin urologist suna kira ga majiyyatan da kada su jira a yi musu tiyatar prostate, suna yi musu barazanar mutuwa da wuri idan ba haka ba. Ralph Blum, majinyacin ciwon daji na prostate, wani likitan urologist ya gaya masa, "Ba tare da tiyata ba za ku mutu nan da shekaru biyu." Mutane da yawa za su tuna cewa irin wannan barazanar mutuwa ta kasance siffa ta gama gari na haɓaka allurar Covid mRNA.
Yin la'akari da tiyatar prostate yana da haɗari daban-daban, ciki har da mutuwa da nakasa na dogon lokaci, tun da hanya ce mai wuyar gaske, har ma da sabuwar fasahar mutum-mutumi. A cewar Dr. Scholz, kusan 1 cikin 600 tiyatar prostate na haifar da mutuwar majiyyaci. Yawancin kashi mafi girma suna fama da rashin ƙarfi (15% zuwa 20%) da rashin ƙarfi bayan tiyata. Tasirin tunani na waɗannan illolin ba karamar matsala ba ce ga maza da yawa.
In light of the significant risks and little proven benefit of treatment, Dr. Scholz censures "the urology world's persistent overtreatment mindset." A bayyane yake, yawan gwajin PSA ya haifar da haifar da wahala mara amfani ga maza da yawa. Kwanan nan, lamarin Covid ya kasance wani lamari mai ban mamaki na wuce gona da iri na likita.
Littafin Ablin da Piana ya yi wani abin lura wanda kuma ya ba da haske mai haske game da martanin likitancin na Covid: "Shin yanke sabbin abubuwa da ke kawo sabbin fasahar likitanci a kasuwa abu ne mai kyau ga masu amfani da kiwon lafiya? Amsar ita ce eh, amma idan sabbin fasahohin da ke shiga kasuwa sun tabbatar da fa'ida kan wadanda suka maye gurbinsu."
Wannan batu na ƙarshe ya shafi Japan a yanzu, inda mutane suke aka bukaci a karba Ƙirƙirar mRNA na gaba-ƙarni mai ƙarfi na mRNA Covid rigakafin. Alhamdu lillahi, da alama akwai lamba tana adawa a wannan karon.
-
Bruce Davidson farfesa ne a fannin ilimin ɗan adam a Jami'ar Hokusei Gakuen a Sapporo, Japan.
Duba dukkan posts
